Osteoarthritis (OA) is associated with past biomechanical injury to cartilage and with aging. However, biomechanical injury and aging do not inevitably lead to OA. This proposal will focus on chondrocyte-centered innate inflammatory mechanisms in OA. We have characterized cartilage catabolism- promoting effects on chondrocytes for inflammation-mediated release of the multifunctional protein transglutaminase 2 (TG2). TG2 is abundant in the OA cartilage extracellular matrix and TG2 transamidation catalytic activity increases in aging cartilage. We observed that TG2 is a biomarker of OA severity, and we validated that global TG2 knockout is protective for instability-induced knee OA in mice. To pinpoint biomechanical injury and stress induced cartilage innate inflammatory responses that provide a foundation upon which OA is then triggered or accelerated, we will examine the linkage of TG2 release and XBP1 (X-box binding protein 1) activation in chondrocyte innate inflammation, proposed by us as a central switching mechanism for OA development and progression. XBP1 activation is specific to activation of ER stress, and successful resolution of ER stress promotes cell recovery and survival from injury. However, XBP1 activation also plays a central role in multiple organ models of innate inflammation, including via Toll-like receptor activation. We observe that biomechanical injury induces activation of ER stress in chondrocytes. Moreover, we detect active XBP1 increased in human knee OA chondrocytes. We also observe that cultured TG2 deficient chondrocytes have decreased XBP1 activation, but that extracellular TG2 induces XBP1 activation. Furthermore, we have generated cartilage-specific XBP1 knockout mice to probe for XBP1 function in chondrocytes. Here, we will test a hypothetical model in which TG2 and XBP1, by transducing and/or amplifying responses to biomechanical injury and oxidative stress, switch on chondrocyte innate inflammatory stress to promote OA development and progression. We specifically aim to: 1. Test the hypothesis that TG2 increases biomechanical injury-induced and oxidative stress-related catabolic and apoptotic responses of cultured chondrocytes mediated by HIF-2alpha activation and TG2 guanine nucleotide binding. 2. Test the hypothesis that TG2 increases injury and oxidative stress-induced catabolic and apoptotic responses of cultured chondrocytes critically mediated by XBP1 activation and decreased AMPK activity. 3. Test the hypothesis, in complementary studies in mice, that both cartilage-specific TG2 and XBP1 deficiency are protective against development and progression of OA. Completion of these studies will shed new light on the pathogenesis of OA related to biomechanical injury and aging, and identify potential new therapeutic targets.

Public Health Relevance

to the VA Mission and Health Care in the USA: OA leads to intractable chronic pain, loss of mobility, decreased social independence, and physical incapacity, and enormous financial costs. Twelve percent of the overall burden of OA arises after joint trauma. Athletic capability is paramount for survival in military basic training and successful service. Individuals with a medical waiver for knee problems are 1.4 times more likely to be hospitalized for any diagnoses, and 8.0 times more likely to be militarily discharged. In the Armed Forces, 30% to 50% of disability cases are due to injury, and the leading conditions are degenerative lower back and knee conditions. A direct relationship exists for OA with prior joint trauma and aging in the VA and other health care systems, and in VISN22, for example, ~40% of veteran patients are 65 years of age or older, and most people over age 65 have OA. We urgently need new therapy targets for OA, since there are currently no disease-modifying drugs.

National Institute of Health (NIH)
Veterans Affairs (VA)
Non-HHS Research Projects (I01)
Project #
Application #
Study Section
Immunology and Dermatology A (IMMA)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
VA San Diego Healthcare System
San Diego
United States
Zip Code
Dalbeth, Nicola; Choi, Hyon K; Terkeltaub, Robert (2017) Review: Gout: A Roadmap to Approaches for Improving Global Outcomes. Arthritis Rheumatol 69:22-34
Liu-Bryan, Ru; Terkeltaub, Robert (2015) Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol 11:35-44
Serrano, Ramon L; Yu, Weifang; Terkeltaub, Robert (2014) Mono-allelic and bi-allelic ENPP1 deficiency promote post-injury neointimal hyperplasia associated with increased C/EBP homologous protein expression. Atherosclerosis 233:493-502
Gruber, Barry L; Couto, Ana Rita; Armas, Jácome Bruges et al. (2012) Novel ANKH amino terminus mutation (Pro5Ser) associated with early-onset calcium pyrophosphate disease with associated phosphaturia. J Clin Rheumatol 18:192-5